According to the U.S. Food and Drug Administration, high doses of the antidepressant Celexa (citalopram) could trigger changes in a patient’s heart rhythm. In some cases, the abnormal rhythms could be fatal. As a result, the FDA has revised the label lowering the approved maximum dose of the drug to 40 mg per day.
The revision was based on reports and clinical trials of patients taking 60 mg of citalopram per day. In the trials, those patients were at increased risk of unsafe changes to the electrical activity of the heart, a condition known as prolongation of the QT interval. The QT interval prolongation led to abnormal heart rhythms especially in patients with underlying heart conditions or those who have low levels of potassium and magnesium in the blood.
New labels for Celexa and its generics will include a warning about the heart risks. Current Celexa users taking higher doses should talk to their doctors. The FDA encourages patients experiencing irregular heartbeat, shortness of breath, dizziness or fainting to seek immediate care.
Messa & Associates is available to handle cases involving heart attacks or other heart injuries related to Celexa. Our attorneys are experienced at have handled dozens of cases involving drugs and drug product injuries. Our attorneys have successfully pursued litigation and obtained verdicts and settlements for victims suffering from these injuries. If you or a loved one has used the antidepressant Celexa and suffered a serious heart condition or death as a result, please contact us at 1-877-MessaLaw.
Manufacturers of High Security Registration Plates.
ReplyDeletecelex